Twin Securities »

Day One Biopharmaceuticals I shares owned by Twin Securities

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Twin Securities

Quarter filed Position value Share count Share price at filing
2026-03-31 $678k 32k 21.44

More positions owned by Twin Securities

Electronic Arts (EA)
Warner Bros Discovery Com Ser A (WBD)
Clearwater Analytics Hldgs I Cl A (CWAN)
Hologic
Kenvue (KVUE)
Revolution Medicines (RVMD)
Arcellx Common Stock (ACLX)
Terns Pharmaceuticals (TERN)
Apellis Pharmaceuticals (APLS)
Onestream Cl A
Take-Two Interactive Software (TTWO)
Day One Biopharmaceuticals I (DAWN)
Atrium Therapeutics (RNA)
Acuren Corporation (TIC)
Manchester Utd Ord Cl A (MANU)

View all positions for Twin Securities

Top funds holding Day One Biopharmaceuticals I

BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
FMR
Glazer Capital
State Street Corporation
Deerfield Management Company
Vanguard Capital Management
Balyasny Asset Management
CNH Partners
UBS Group
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
Bank of America Corporation

View all funds holding Day One Biopharmaceuticals I